Stock 600613 SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Equities

600613

CNE000000453

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
6.53 CNY +1.08% Intraday chart for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. +8.83% -14.19%
Apr. 29 Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

Number of employees: 1,570

Sales per Business

CNY in Million2021Weight2022Weight Delta
Other
40.4 %
769 33.4 % 965 40.4 % +25.38%
Antineoplastic Drug Series
35.5 %
899 39.0 % 848 35.5 % -5.65%
Classic Chinese Medicine Cough Series
9.2 %
234 10.2 % 219 9.2 % -6.77%
Skin Topical Antibacterial Series
4.2 %
139 6.1 % 101 4.2 % -27.73%
Three High Chronic Disease Product Series
3.9 %
- - 93 3.9 % -
Miao Medicine Strengthening Muscle and Bone Series
3.4 %
95 4.1 % 82 3.4 % -13.74%
Classic Tonic Product Series
1.9 %
65 2.8 % 46 1.9 % -29.66%
Magic Doll Medicine
1.5 %
- - 35 1.5 % -

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
2,303 100.0 % 2,389 100.0 % +3.72%

Managers

Managers TitleAgeSince
Bin Feng CEO
 Chief Executive Officer 52 05-06-30
Ke Jing Wu SEC
 Corporate Secretary 47 17-04-27

Members of the board

Members of the board TitleAgeSince
Shi Gui Chen BRD
 Director/Board Member 61 20-06-28
Bin Feng CEO
 Chief Executive Officer 52 05-06-30
Zhi Ting Zhang BRD
 Director/Board Member 80 20-06-25
Tao Tao Zhang CHM
 Chairman 43 14-06-25
Tao Wu BRD
 Director/Board Member 52 13-10-15
Yu Bo Xia CHM
 Chairman 52 14-06-25
Dan Xu BRD
 Director/Board Member 53 14-06-25
Lan Hu BRD
 Director/Board Member 55 07-06-21
Cong Yan Li BRD
 Director/Board Member 58 20-06-28
Ke Jing Wu SEC
 Corporate Secretary 47 17-04-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,751,650 54,751,650 ( 100.00 %) 0 49.01 %
Stock B 1 479,319,978 207,011,562 ( 43.19 %) 0

Shareholders

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
0.0235 %
112,700 0.0235 % 100 889 ¥
HFT Investment Management Co., Ltd.
0.009284 %
44,500 0.009284 % 39 836 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.007928 %
38,000 0.007928 % 34 018 ¥
Truvalue Asset Management Co. Ltd.
0.001606 %
7,700 0.001606 % 6 893 ¥
CICC Fund Management Ltd.
0.000772 %
3,700 0.000772 % 3 312 ¥
Lion Fund Management Co., Ltd.
0.000146 %
700 0.000146 % 627 ¥
Gfund Management Co., Ltd.
0.000021 %
100 0.000021 % 90 ¥

Company contact information

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Room 613, Changfa Building 128, Weihai Road

200003, Shanghai

+

http://www.gzsq.com
address Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.(600613)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD. Stock Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
-14.19% 466M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.01% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.74% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.19% 326B
ABBVIE INC. Stock AbbVie Inc.
+2.86% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-4.50% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600613 Stock
  4. Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.